Search results for "Vaccines"
First COVID-19 vaccine receives interim recommendation, hydroxychloroquine ineffective for prophylaxis, and more
The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. Other research looked at postexposure prophylaxis, household SARS-CoV-2 transmission, and persistent COVID-19 symptoms.
https://immattersacp.org/weekly/archives/2020/12/15/1.htm
15 Dec 2020
New data on COVID-19 vaccines' effectiveness over time, boosters, barriers to uptake
Multiple recent studies assessed the effectiveness of the COVID-19 vaccines at different time intervals after vaccination, while others looked at the impact of booster shots. Results of a survey suggested that racial differences in vaccine uptake may be attributable to social barriers.
https://immattersacp.org/weekly/archives/2021/12/07/1.htm
7 Dec 2021
Latest COVID-19 research looks at vaccines' efficacy, thrombocytopenia risk
Thrombosis with thrombocytopenia is a risk with the Johnson & Johnson (Janssen) vaccine, but not those using mRNA technology, one study found, while other research quantified the vaccines' effectiveness over time. A trial found that monoclonal antibodies reduced progression from asymptomatic to symptomatic infection.
https://immattersacp.org/weekly/archives/2022/01/18/1.htm
18 Jan 2022
MKSAP Quiz: Evaluation during a pre-employment examination
A 37-year-old man is evaluated during a pre-employment examination. He is starting a new job as a medical assistant in a primary care office. He has received influenza, COVID-19, and tetanus and diphtheria toxoids vaccines. What is the most appropriate additional vaccine to administer?
https://immattersacp.org/weekly/archives/2023/06/27/3.htm
27 Jun 2023
Research, regulators consider booster dose of COVID-19 vaccine
FDA advisors recommended boosters for older and high-risk patients. The latest COVID-19 research looked at vaccine effectiveness, remdesivir's effects, an early indicator of vaccine-induced immune thrombotic thrombocytopenia, and rates of follow-up after hospitalization.
https://immattersacp.org/weekly/archives/2021/09/21/1.htm
21 Sep 2021
COVID-19 pill study; new vaccine recommendation plus data on waning efficacy, low risk of postvaccine myocarditis; updates on experimental treatments
A peer-reviewed study showed molnupiravir reduced hospitalizations and deaths in high-risk patients, the CDC favored mRNA vaccines over J&J's, experts explained potential issues with waning efficacy data, and a study quantified the low risk of myocarditis after vaccination.
https://immattersacp.org/weekly/archives/2021/12/21/1.htm
21 Dec 2021
Latest COVID-19 research on dexamethasone, hydroxychloroquine, a vaccine, tocilizumab
Peer-reviewed details on the recent trial of dexamethasone were released, and two new trials found no benefit to early treatment with hydroxychloroquine. Positive data from a phase 1 vaccine trial were also published, as was another study of tocilizumab.
https://immattersacp.org/weekly/archives/2020/07/21/1.htm
21 Jul 2020
Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies
The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021
New research on mixed vaccine boosters, long-term outcomes, omicron severity
A study found mixing and matching of COVID-19 vaccines to be safe and effective, other research showed ongoing symptoms to be common at one year after infection, the CDC analyzed the severity of omicron, and the FDA revised outpatient treatment authorizations.
https://immattersacp.org/weekly/archives/2022/02/01/1.htm
1 Feb 2022
COVID-19 vaccine protection, primary care delays and international differences during the pandemic
An analysis of the omicron surge found that unvaccinated people were 23 times more likely to be hospitalized than those who got a booster. Two studies assessed how the pandemic delayed primary care, and an international study tied lower infection rates to trust in government.
https://immattersacp.org/weekly/archives/2022/02/08/1.htm
8 Feb 2022